David S Cooper

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. doi request reprint Subclinical thyroid disease
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Lancet 379:1142-54. 2012
  2. doi request reprint Hyperthyroidism in pregnancy
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD, USA Electronic address
    Lancet Diabetes Endocrinol 1:238-49. 2013
  3. ncbi request reprint Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Thyroid 19:1167-214. 2009
  4. ncbi request reprint TSH suppressive therapy: an overview of long-term clinical consequences
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, USA
    Hormones (Athens) 9:57-9. 2010
  5. ncbi request reprint Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    Sinai Hospital of Baltimore and Johns Hopkins University School of Medicine, MD, USA
    Thyroid 16:109-42. 2006
  6. ncbi request reprint A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
    Pamela R Schroeder
    Johns Hopkins Medical Institutions, Division of Endocrinology and Metabolism, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:878-84. 2006
  7. ncbi request reprint Antithyroid drugs
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore 21215, USA
    N Engl J Med 352:905-17. 2005
  8. ncbi request reprint Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer
    Shuiying Hu
    Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:98-104. 2006
  9. ncbi request reprint Subclinical thyroid disease: consensus or conundrum?
    David S Cooper
    Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, MD 21204, USA
    Clin Endocrinol (Oxf) 60:410-2. 2004
  10. ncbi request reprint The incidence and prevalence of thyroid autoimmunity
    Donald S A McLeod
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Suite 333, 1830 E Monument St, Baltimore, MD 21287, USA
    Endocrine 42:252-65. 2012

Collaborators

Detail Information

Publications22

  1. doi request reprint Subclinical thyroid disease
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Lancet 379:1142-54. 2012
    ..Large-scale randomised trials are urgently needed to inform how to best care for individuals with subclinical thyroid disease...
  2. doi request reprint Hyperthyroidism in pregnancy
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD, USA Electronic address
    Lancet Diabetes Endocrinol 1:238-49. 2013
    ....
  3. ncbi request reprint Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Thyroid 19:1167-214. 2009
    ..Since the publication of the American Thyroid Association's guidelines for the management of these disorders was published in 2006, a large amount of new information has become available, prompting a revision of the guidelines...
  4. ncbi request reprint TSH suppressive therapy: an overview of long-term clinical consequences
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, USA
    Hormones (Athens) 9:57-9. 2010
    ..g., osteoporosis, cardiovascular disease, diabetes), is uncertain and requires a high degree of clinical experience and judgment...
  5. ncbi request reprint Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    Sinai Hospital of Baltimore and Johns Hopkins University School of Medicine, MD, USA
    Thyroid 16:109-42. 2006
  6. ncbi request reprint A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
    Pamela R Schroeder
    Johns Hopkins Medical Institutions, Division of Endocrinology and Metabolism, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:878-84. 2006
    ..Levothyroxine (L-T4) withdrawal for thyroglobulin measurement and whole body scanning increases these tests' sensitivities but causes hypothyroidism. Recombinant human TSH (rhTSH) enables testing without L-T4 withdrawal...
  7. ncbi request reprint Antithyroid drugs
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore 21215, USA
    N Engl J Med 352:905-17. 2005
  8. ncbi request reprint Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer
    Shuiying Hu
    Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:98-104. 2006
    ..Serum DNA methylation markers may potentially be useful in diagnosing thyroid cancer and monitoring its recurrence...
  9. ncbi request reprint Subclinical thyroid disease: consensus or conundrum?
    David S Cooper
    Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, MD 21204, USA
    Clin Endocrinol (Oxf) 60:410-2. 2004
  10. ncbi request reprint The incidence and prevalence of thyroid autoimmunity
    Donald S A McLeod
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Suite 333, 1830 E Monument St, Baltimore, MD 21287, USA
    Endocrine 42:252-65. 2012
    ..Further research is required to assess the possibility of changing disease patterns of autoimmune thyroid disease as opposed to simple changes in diagnostic thresholds...
  11. ncbi request reprint Thyroid MALT lymphoma in patients with a compressive goiter
    Lisa M Earnest
    Division of Head and Neck Surgery, Department of Otolaryngology Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Head Neck 28:765-70. 2006
    ..Although they tend to have an indolent course, these lymphomas present a diagnostic challenge requiring a high level of suspicion in patients at increased risk of development...
  12. ncbi request reprint Approach to the patient with subclinical hyperthyroidism
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, 2435 West Belvedere Avenue, Hoffberger Building, Suite 56, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 92:3-9. 2007
    ..Nevertheless, it seems reasonable to treat older individuals whose serum TSH levels are less than 0.1 mU/liter and certain high-risk patients, even when the serum TSH is between 0.1 and the lower limit of the normal range...
  13. pmc Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008
    Ana B Emiliano
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, 1830 East Monument Street, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 95:2227-33. 2010
    ..However, little is known about the rate of use of these drugs and the prescribing practices of physicians treating hyperthyroidism...
  14. ncbi request reprint Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 88:3474-81. 2003
  15. ncbi request reprint The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer
    Milena Basaria
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
    Am J Med 112:721-5. 2002
    ..The use of recombinant thyrotropin has fewer adverse effects than does the alternative, which is withdrawal of thyroid hormone replacement, although nausea and headache have been reported. However, recombinant thyrotropin is expensive...
  16. ncbi request reprint A 2013 survey of clinical practice patterns in the management of primary hypothyroidism
    Henry B Burch
    Endocrinology Division H B B, Walter Reed National Military Medical Center, Bethesda, Maryland 20889, and Uniformed Services University of Health Sciences, Bethesda, Maryland 20814 Endocrinology Section K D B, Washington Hospital Center, Washington, DC 20010 Georgetown University Medical Center K D B, Washington, DC 20007 Division of Endocrinology D S C, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 Division of Endocrinology J V H, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215 and Harvard Medical School J V H, Boston, Massachusetts 02115
    J Clin Endocrinol Metab 99:2077-85. 2014
    ..In 2012, comprehensive clinical practice guidelines (CPGs) were published regarding the management of hypothyroidism...
  17. ncbi request reprint Amiodarone and the thyroid
    Shehzad Basaria
    Department of Medicine, Division of Endocrinology, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, Maryland, USA
    Am J Med 118:706-14. 2005
    ....
  18. doi request reprint Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis
    Donald S A McLeod
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 97:2682-92. 2012
    ..TSH is the major growth factor for thyrocytes and may have a causative role in thyroid cancer...
  19. ncbi request reprint Amyloidosis: role of fine-needle aspiration
    Shehzad Basaria
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Thyroid 13:313-4. 2003
  20. ncbi request reprint The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial
    Milena Braga
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
    Thyroid 12:135-9. 2002
    ..Similar cure rates and time required to achieve hypothyroidism after radioiodine were observed when patients were pretreated with methimazole compared to nonpretreated patients...
  21. pmc Clinical significance of discordant findings between pre-therapy (123)I and post-therapy (131)I whole body scan in patients with thyroid cancer
    Paco E Bravo
    Division of Nuclear Medicine, Department of Radiology, Johns Hopkins University Baltimore, MD, USA
    Int J Clin Exp Med 6:320-33. 2013
    ..In our study, pre-RAI scans showed a low yield to detect iodine-avid distant metastatic disease when compared to post-RAI scans...
  22. ncbi request reprint Dirty nails
    Hans K Ghayee
    Sinai Hospital, Department of Medicine, 2401 West Belvedere Avenue, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 90:2428. 2005